Head and Neck Cancer
4 competing products in clinical development for Head and Neck Cancer.
Pipeline by Phase
Phase 22
Phase 32
All Products (4)
| Product | Company | Stage | Status | Hype |
|---|---|---|---|---|
| cevimeline hydrochloride | Daiichi Sankyo | Phase 3 | Completed | 40 |
| Nivolumab + Ipilimumab + Cetuximab/Erbitux + Cisplatin/Platinol + Carboplatin/Paraplatin + Fluorouracil/Adrucil | Ono Pharmaceutical | Phase 3 | Completed | 40 |
| Docetaxel + Erlotinib + Chemotherapy | Astellas Pharma | Phase 2 | Completed | 35 |
| Ozuriftamab Vedotin + Pembrolizumab + Evalstotug (BA3071) + Cetuximab | BioAtla | Phase 2 | Completed | 25 |